Patient Acquisitions And Cost Cuts Will Yield Mixed REIT Prospects

Published
04 Apr 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
US$17.70
16.3% undervalued intrinsic discount
24 Jul
US$14.81
Loading
1Y
2.2%
7D
2.5%

Author's Valuation

US$17.7

16.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on24 Apr 25
Fair value Decreased 11%

Shared on17 Apr 25
Fair value Increased 12%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25